Byteflies

Founded in 2015 by Hans Danneels and Hans De Clercq, Byteflies is a medical technology company based in Antwerp, Belgium, that provides end-to-end services for remote patient monitoring. The company operates in the B2B market, primarily serving pharmaceutical companies, hospitals, and clinical research organizations. Its business model focuses on providing a full-service platform that includes wearable sensors, data processing, and an analytics dashboard, effectively streamlining the development of wearable health applications.

Byteflies' core offering is a versatile, medically certified telemonitoring platform. This platform features the 'Sensor Dot,' a compact, comfortable, and modular wearable device that can be configured to monitor a wide range of physiological signals. These include cardiovascular activity, brain activity, respiration rate, and physical activity, allowing for applications in diverse fields like cardiology, neurology, and pneumology. The technology is designed to capture continuous, high-quality data from patients in their everyday environments, which is then sent to a secure cloud portal for analysis. The company offers specific applications such as EpiCare@Home for epilepsy patients and CardioCare@Home for stroke patients. A key differentiator is the system's ability to handle the entire workflow, from shipping devices to patients' homes to integrating the processed data into clinicians' dashboards, thus reducing the burden on healthcare staff.

The company's platform is utilized to accelerate clinical trials and support value-based healthcare models. By providing a flexible, multi-sensor system, Byteflies allows clients like hospitals and pharmaceutical firms to avoid working with multiple, disparate monitoring providers. Revenue is generated through a pay-per-use system, which eliminates the need for clients to make significant upfront investments. The company has established partnerships with prominent organizations, including UCB, and research institutions like the University of Leuven, Oxford University, and MIT. Significant funding milestones include a €4.5 million financing round in October 2022 from investors like Sensinnovat and several angel investors to support its growth and platform development.

Keywords: remote patient monitoring, wearable sensors, medical technology, clinical trials, digital biomarkers, telemonitoring, virtual care, healthcare analytics, B2B medtech, vital signs monitoring, continuous monitoring, real-world data, personalized healthcare, patient-centric care, digital health solutions, cardiovascular monitoring, neurology monitoring, epilepsy monitoring, Sensor Dot, ISO13485